Poster Identification of optimal treatment sequence and acquired resistance mechanisms of ALK inhibitors using EML4-ALK transgenic mouse model
페이지 정보
작성자 DAAN
조회 54회 작성일 24-02-16 15:40
조회 54회 작성일 24-02-16 15:40
본문
| Journal | AACR |
|---|---|
| Name | 표경호, 임선민 |
| Year | 2018 |
첨부파일
-
2018-AACR-Poster-ALK.pdf (813.9K)
0회 다운로드 | DATE : 2024-02-16 15:40:37
- 이전글Finding the optimal strategy of incorporating immune checkpoint inhibitor in ALK-positive non-small-cell lung cancer using EML4- ALK transgenic mouse model 24.02.16
- 다음글A machine learning based clinical decision support system (CDSS) for anti-PD-1 treatment using non-invasive blood marker and clinical information for lung cancer patients 24.02.16